Nicotinell (Nicotine Polacrilex)

Nicotine polacrilex is a polymer‑bound nicotine that releases the active ingredient slowly when placed in the mouth. It partially stimulates nicotinic acetylcholine receptors in the brain, delivering a modest nicotine dose that lessens withdrawal while allowing the receptors to adapt, supporting eventual cessation.

The appropriate dose of Nicotinell is determined by the prescribing healthcare professional based on the individual’s smoking history, dependence level, and treatment plan. Patients should follow the specific instructions provided by their clinician and the product labeling.

Safety of nicotine replacement therapy during pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Nicotinell.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicotinell delivers nicotine via a buccal formulation, offering rapid absorption through the oral mucosa. Compared with patches, it provides quicker onset of action, while being less invasive than inhalers. Its dosing flexibility can be advantageous for patients who prefer short‑acting relief without the skin irritation sometimes associated with patches.

Store Nicotinell at ambient temperature, below 25 °C, in its original packaging to protect from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged or the product appears discolored.

Place the tablet or lozenge between the gum and cheek, allowing it to dissolve slowly. Do not chew or swallow whole. Avoid eating or drinking for at least 15 minutes after placement to ensure optimal absorption through the buccal mucosa.

Serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and cardiovascular events like chest pain or palpitations. If any of these occur, discontinue use immediately and seek medical attention.

Nicotinell should not be used by individuals who are not currently tobacco users, those with known hypersensitivity to nicotine or any excipients, patients with recent myocardial infarction or unstable angina without medical advice, and children or adolescents under 18 years of age.